J.G. Chemicals Share Price: Target 2026 to 2030, Valuation and Risks

J.G. Chemicals share price today

Anyone typing J.G. Chemicals share price into a search box is looking at an unusual kind of Indian micro-cap. This is a fifty-year-old Kolkata company built around a single chemistry: turning zinc into zinc oxide and zinc sulphate, sold under the Luxmi brand into tyres, ceramic glaze, paint, batteries, animal feed and pharmaceutical formulations. The investment question is whether a converter of one metal, running on single-digit-to-low-double-digit margins, deserves the earnings multiple the market is currently paying for it.

At the 10 September 2026 close, Yahoo Finance showed a price of about ₹591.15, market capitalisation near ₹2,322 crore and trailing EPS of ₹19.19. That works out to roughly 30.8 times trailing earnings and 4.43 times a book value of ₹133.76 per share. The quote above keeps moving after publication; every ratio and scenario input below stays fixed to that cut-off date.

The twelve-month range tells its own story. The low is ₹305.20 and the high is ₹651.30, so the stock has close to doubled from the bottom of that range and sits about 9.24% below the top. Five weeks earlier, on 5 August 2026, the figures read on Screener.in put the same company at a 52-week high of ₹552.80 and a market value of ₹2,166 crore. In other words, the share made a fresh high somewhere in between. A stock that keeps setting new highs is being re-rated, and re-rating is the component of a return that unwinds fastest when sentiment turns.

What J.G. Chemicals actually makes

The company was incorporated in 1975 and is headquartered in Kolkata. It manufactures and sells zinc oxide and zinc sulphate in India under the Luxmi brand. The customer list in the company description is long and spans very different kinds of buyers: rubber, ceramics, paints, pharmaceuticals and cosmetics, electronics and batteries, specialty chemicals, sanitaryware, adhesives, surface treatment chemicals, varistors, semiconductors, catalysts, agrochemicals, lubricants, oil and gas, and animal feed.

That breadth matters less than it first appears, because all of it rests on the same raw material. A useful way to read the list is by the character of the demand rather than by industry name.

Demand cluster	Industries named in the company description	Character of that demand
Volume industrial	Rubber, ceramics, sanitaryware, paints	Tied to vehicle and construction output; large tonnage, price-led buying
Energy and electronics	Batteries, electronics, varistors, semiconductors	Smaller tonnage, tighter specification, qualification-led
Life sciences and feed	Pharmaceuticals and cosmetics, animal feed, agrochemicals	Purity grade and documentation matter more than headline price
Industrial specialties	Adhesives, surface-treatment chemicals, catalysts, lubricants, oil and gas	Widens the customer base without changing the input

The strategic prize in a business shaped like this is mix. Selling the same compound into a battery or pharmaceutical qualification is a different economic proposition from selling it by the tonne into rubber compounding, even though the process and the raw material are shared. Nothing in the captured data breaks revenue down by grade or by end market, so mix improvement is a thing to look for in future filings rather than something already demonstrated in the numbers available here.

Where the J.G. Chemicals share price gets its direction

A converter’s profit and loss account has a particular shape. Most of the rupee value of what it sells is the metal it bought, and the company keeps the spread between input cost and realisation, less conversion cost. The trailing figures are consistent with exactly that structure.

Trailing twelve-month measure	Reading at 10 September 2026	Why it matters
Revenue	₹1,071 Cr	Market capitalisation is about 2.2 times annual sales
EBITDA	₹96 Cr	The absolute pool of operating profit is small for the revenue base
Operating margin	10.25%	About ten paise of operating profit per rupee of sales
Net profit margin	7.02%	Leaves little room between a good year and a poor one
Implied net profit	About ₹75 Cr	7.02% of ₹1,071 Cr, and consistent with EPS of ₹19.19 on 3.92 crore shares
Revenue growth, year on year	44.8%	A very large step up
Earnings growth, year on year	58.8%	Profit grew faster than sales, which is what operating leverage on a thin margin looks like

Return on capital employed is dealt with separately below, because the 18.13% figure used throughout this article is a Screener.in reading taken on 5 August 2026 rather than a Yahoo trailing measure captured at the September cut-off, and mixing the two dates inside one table would misstate when it was read.

The relationship between the last two growth rates is the one to understand. At a 10.25% operating margin, a small movement in the spread between what the company pays for its input and what it charges for the finished oxide produces a disproportionate movement in profit. That works powerfully in both directions. Earnings rising 58.8% while revenue rises 44.8% is not evidence of a structural improvement in the franchise; it is arithmetic that can reverse with equal force if realisations normalise.

Growth in the last twelve months ran ahead of the five-year record

The longer record is more sober than the trailing year. The five-year figures read on Screener.in on 5 August 2026 show sales compounding at 17.52% and profit compounding at 23.8%, alongside a return on capital employed of 18.13% from that same 5 August reading. All three are good numbers for a chemical converter, and the return on capital is the strongest single figure anywhere in this article. None of them is close to the 44.8% and 58.8% the last twelve months delivered.

Growth measure	Five-year compound rate (5 Aug 2026)	Trailing twelve months (10 Sep 2026)	Gap
Sales	17.52%	44.8%	Sales ran at roughly 2.6 times the long-run rate
Profit	23.8%	58.8%	Profit ran at roughly 2.5 times, so the profit-over-sales gap is no wider than the five-year record

That last comparison is easy to miss and worth pausing on. Profit outran sales in the trailing year, but it outran sales by a similar proportion over the whole five-year record, so the step-up is not evidence of a newly wider margin. It is the same operating leverage the business has always had, applied to a much bigger revenue jump.

Two readings compete here, and the captured data does not settle the argument. The constructive one is that capacity, mix or market share genuinely stepped up and the five-year average understates the company as it now exists. The cautious one is that a favourable input-price cycle flattered a single year, and the five-year rate is the honest description of the underlying business. Any forecast built on the trailing year alone is implicitly betting on the first reading without evidence.

A balance sheet with almost no debt

Whatever the argument about growth, solvency is not in question. Total debt is ₹6 crore against ₹160 crore of cash, which is a net cash position of about ₹154 crore, or roughly 6.6% of the market capitalisation. Debt to equity is 1.19%.

Balance-sheet measure	10 September 2026 reading	Reading
Total debt	₹6 Cr	Effectively unlevered
Total cash	₹160 Cr	Comfortably covers the borrowings many times over
Net cash	About ₹154 Cr	Cash minus debt; a cushion, not a growth engine
Debt to equity	1.19%	Balance-sheet risk is not the issue for this company
Book value per share	₹133.76	Implies net worth of about ₹524 Cr on 3.92 crore shares
Price to book	4.43×	The market pays well above accounting net worth
Dividend yield	0.18%	Income is not part of the case at this price

A near-debt-free balance sheet is a real strength for a cyclical business, because it means a bad year is a bad year rather than an existential one. It is also, at 4.43 times book, already priced in. The debt-to-equity ratio here is about as low as an operating company gets, which removes one risk from the list and shifts the entire question onto earnings power and multiple.

Ownership: the promoter group holds three-quarters

The promoter group held 76.45% of the equity at the cut-off. That leaves a free float of roughly 23.55%, or something near ₹550 crore of tradeable market value at the current price.

High promoter ownership cuts both ways. It aligns the controlling family with minority holders and signals that nobody has been selling down. It also means a thin float, which magnifies price moves in both directions, widens impact cost for anyone dealing in size, and can keep the stock out of index and institutional mandates that require a minimum public shareholding. The split of the remaining quarter between domestic institutions, foreign investors and retail holders was not part of the data captured for this article, and neither was any pledge figure. Both are worth checking in the current shareholding pattern filed with the exchange before drawing conclusions about who owns the float.

What this research does not cover

This is worth stating plainly rather than burying. No year-by-year financial tables and no quarterly rows were captured for J.G. Chemicals in this pass. Because of that, this article contains no quarterly-results section and no five-year revenue and profit table, and it deliberately avoids inventing either.

The multi-year picture here rests on two things only: the trailing twelve-month figures from Yahoo Finance dated 10 September 2026, and the five-year sales CAGR, profit CAGR and return on capital employed read from Screener.in on 5 August 2026. Several ratios a full review would normally use are simply absent: return on equity, EV/EBITDA, PEG, the operating-margin history, the pledge percentage and the institutional shareholding split. Anyone relying on this page should open the Screener page and the company’s exchange filings listed at the end and fill those gaps directly.

Valuation at the research cut-off

Valuation measure	10 September 2026 reading	Interpretation
Price	₹591.15	Completed-session close, a fixed research input
Market capitalisation	₹2,322 Cr	Micro-cap; liquidity and the thin free float both matter
Trailing EPS	₹19.19	Yahoo Finance trailing figure
Recalculated P/E	30.81×	Price divided by trailing EPS; the reported figure is 30.87
Price to book	4.43×	Against book value of ₹133.76
Return on capital employed	18.13% (5 Aug 2026 reading)	The number doing most of the work in the bull case
Dividend yield	0.18%	Negligible as a return component
52-week range	₹305.20 to ₹651.30	The stock has travelled a long way inside twelve months

Thirty-one times trailing earnings is a specialty-chemical multiple applied to a profit and loss account with a 10.25% operating margin. It can be defended if the company is genuinely migrating toward higher-specification grades and if the five-year compounding rate proves to be the floor rather than the ceiling. It offers very little protection if the trailing year turns out to be a cyclical peak. The mechanics of why the starting multiple matters so much are set out in the P/E ratio guide, and the method used for every scenario grid on this site is described in how to value a stock.

Valuation framework

The scenario model starts with TTM EPS of ₹19.19. For each year it applies EPS_TTM × (1 + growth)^(year − 2026 + 112/365) × exit P/E, then rounds the result to the nearest ₹5. The 112/365 factor represents the fraction of the first forecast year remaining from 10 September to 31 December. Dividends are excluded.

Scenario	Annual EPS growth	Exit P/E	Business interpretation
Bear	8%	16×	Realisations normalise, the trailing year proves cyclical, and the market prices the company as the commodity converter it structurally is
Base	14%	26×	Volume growth settles near the long-run sales trend, margins hold, and the multiple drifts modestly below today’s
Bull	20%	34×	Higher-specification grades and electronics or battery demand lift mix, and the market keeps paying a specialty rating

The bear multiple sits at roughly half the present rating, which is deliberate. For a thin-margin business whose earnings can swing with an input cycle, the realistic downside is not merely slower growth but slower growth arriving at the same time as a de-rating. Equally, the bull case pairs strong growth with only a modest expansion above today’s multiple, because assuming both perfect execution and permanent re-rating would simply restate the current enthusiasm as a forecast. These are scenarios, not probability-weighted predictions.

J.G. Chemicals share price target 2026 to 2030

The grid above is generated only from the disclosed EPS, growth and exit-multiple inputs. It models nothing else. It does not account for a change in the input metal’s price, a capacity addition, an equity issue that changes the share count, an acquisition, an exceptional item, a shift in the export or grade mix, or any change in the dividend. It also inherits every limitation of a trailing EPS that was earned in an unusually strong twelve months. Refresh the inputs after the next set of published results before leaning on any of it.

Risks that can break the thesis

The first risk is input concentration. Revenue, cost of goods and the spread between them all track the same metal. That is a single point of exposure no amount of end-market diversity removes, because rubber, ceramics and batteries all buy a product made from the same input.

The second is margin fragility. At a 10.25% operating margin and a 7.02% net margin, two points of spread compression remove a large slice of profit. The 58.8% earnings growth of the trailing year is the same mechanism running the other way, and it should not be extrapolated.

The third is the valuation itself. At 30.8 times earnings and 4.43 times book, the price already assumes the recent step-up is durable. A return to something nearer the 17.52% sales and 23.8% profit compounding of the past five years would still be a good business outcome and could still be a poor share outcome if the multiple contracts at the same time.

The fourth is float and liquidity. With 76.45% held by promoters, the tradeable portion is small enough that exits in size are expensive, and the same thinness that accelerated the move from ₹305.20 to ₹651.30 works in reverse. A dividend yield of 0.18% provides no cushion while waiting.

The fifth is disclosure. Zinc processing sits inside environmental, effluent and hazardous-materials regimes, and a compliance event at a manufacturing site is a company-level rather than a line-item problem. That risk cannot be sized from the figures used here, which is itself a reason for caution.

What would strengthen or weaken the case

The case strengthens if published results show the trailing year’s revenue level holding rather than retracing, if operating margin moves durably above the present 10.25% on a stable input price, if return on capital employed rises from 18.13% toward the low twenties, and if management begins disclosing revenue by grade or end market so that mix improvement can be verified rather than assumed. Growing net cash from ₹154 crore while funding expansion internally would reinforce it.

The case weakens if revenue growth falls back toward or below the 17.52% five-year rate while the multiple stays where it is, if operating margin compresses and the profit decline exceeds the revenue decline, if working capital or receivables expand faster than sales, or if promoter holding starts moving without a stated purpose. A large debt-funded capacity addition would change the risk profile of a currently unlevered balance sheet and would need reassessment on its own terms.

Monitoring scorecard

Question	Constructive evidence	Warning sign
Was the trailing year structural or cyclical?	Revenue holds near the trailing level across further reported periods	Sales retrace toward the five-year trend line
Is margin improving or just cycling?	Operating margin above 10.25% on a stable input cost	Margin compresses while volumes hold
Is the mix genuinely upgrading?	Disclosure of higher-specification or export revenue share	Only aggregate revenue reported, with no grade detail
Is capital still earning?	ROCE holds or rises from 18.13%	ROCE falls as the asset base expands
Is the balance sheet still a strength?	Net cash maintained near ₹154 Cr	Borrowings rise to fund expansion
Is ownership stable?	Promoter stake steady near 76.45%, no pledge	Stake reduction or pledging disclosed

FAQ

What is the J.G. Chemicals share price target for 2026?

Every 2026 figure in the grid comes from trailing EPS of ₹19.19, a scenario growth rate and an exit multiple, with only 112 of 365 days of 2026 remaining from the 10 September cut-off. Because that partial year is short, the 2026 column sits close to current earnings multiplied by the scenario multiple, so the multiple assumption does almost all the work. It is a range of arithmetic outcomes, not a forecast.

What is the J.G. Chemicals share price target for 2030?

The 2030 column compounds the same ₹19.19 of trailing earnings forward by just over four years at the scenario growth rate before applying the exit multiple. Small differences in the annual rate compound into large differences by the fifth year, which is why the bear and bull columns separate so widely. The figures are illustrations of the assumptions, not predictions of a price.

What does J.G. Chemicals do?

It manufactures and sells zinc oxide and zinc sulphate in India under the Luxmi brand. The company was incorporated in 1975 and is headquartered in Kolkata, and it supplies industries including rubber, ceramics, paints, pharmaceuticals and cosmetics, electronics and batteries, sanitaryware, adhesives, agrochemicals, lubricants and animal feed.

Who are the promoters of J.G. Chemicals?

The promoter group held 76.45% of the equity at the 10 September 2026 reading, leaving a public float of roughly 23.55%. The individual names inside that promoter block, and any pledge against those shares, are disclosed in the shareholding pattern the company files with the exchange rather than in the figures used for this article.

What is the stock symbol of J.G. Chemicals?

The company trades on the NSE under the symbol JGCHEM, which appears as JGCHEM.NS in Yahoo Finance data and as JGCHEM on Screener.in. The quote widget at the top of this page tracks that symbol.

Related research

• Kronox Lab Sciences share price target
• Fineotex Chemical share price target
• Vinati Organics share price target
• National Aluminium share price target
• How to value a stock: the method behind every target here

Sources and methodology

• J.G. Chemicals on Screener.in
• J.G. Chemicals quote and filings on NSE
• J.G. Chemicals company website

Price, 52-week range, market capitalisation, trailing EPS, book value, the trailing revenue, EBITDA and margin figures, the debt and cash balances, the promoter holding and the dividend yield were all captured on 10 September 2026 from Yahoo Finance, after the completed session. The five-year sales CAGR of 17.52%, the five-year profit CAGR of 23.8% and the 18.13% return on capital employed come from Screener.in and were read on 5 August 2026, as were the ₹2,166 crore market value and ₹552.80 high quoted for that earlier date. The business description, the brand name, the year of incorporation and the list of industries served are as reported in the company profile. Net cash, implied net worth, implied net profit and the free-float percentage are simple arithmetic on those figures and are labelled as such where they appear. Everything beyond that point is analytical judgment: the reading of converter economics, the choice of growth rates and exit multiples in the scenario table, and the assessment of which risks matter most.

---

This article is research and education, not personalised investment advice or a recommendation to transact. Gale is not a SEBI-registered investment adviser. The scenarios are illustrations, not guarantees. Verify current exchange filings, liquidity, corporate actions and suitability, and consult a registered adviser before acting.